Skip to main content
eScholarship
Open Access Publications from the University of California

Ocriplasmin for vitreoretinal diseases.

  • Author(s): Tsui, Irena
  • Pan, Carolyn K
  • Rahimy, Ehsan
  • Schwartz, Steven D
  • et al.
Abstract

Fibronectin and laminin are clinically relevant plasmin receptors in the eye. Located at the vitreoretinal interface, they are cleaved by ocriplasmin (Microplasmin, ThromboGenics, Iselin, NJ), a novel ophthalmic medication. A series of clinical trials to study ocriplasmin for the treatment of vitreoretinal diseases such as vitreomacular traction, macular hole, and exudative age-related macular degeneration are underway. The results are promising and may impact patient care.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View